Can anticoagulants reduce thrombotic risks in patients with paroxysmal nocturnal hemoglobinuria (PNH), and how do they improve overall management of this rare disorder?
Gaurav ChauhanContributor
Can anticoagulants reduce thrombotic risks in patients with paroxysmal nocturnal hemoglobinuria (PNH)?
Share
Anticoagulants can reduce thrombotic risks in PNH patients by preventing clot formation, enhancing survival and reducing complications like strokes.
Anticoagulants are essential in managing PNH as they lower the incidence of life-threatening clots, thereby improving patient outcomes and quality of life.